NCT05045391Active, not recruiting
Pulmonary Aspergillosis in Tuberculosis Patients
Prevalence of Chronic Pulmonary Aspergillosis and Antifungal Drug Resistance of Aspergillus Spp. in Pulmonary Tuberculosis Patients in Uzbekistan
Source: ClinicalTrials.gov · Last updated 4 Apr 2025
Brief summary (registry, in English)
Pulmonary tuberculosis (PTB) is the most common cause of lung destruction, contributing to coinfections development, and Aspergillosis spp. is one of the most important. Diagnosis of chronic pulmonary aspergillosis (CPA) in PTB patients is difficult due to similarity of clinical and radiological data, especially in resource-constrained settings. Differentiation of PTB patients with singling out a group with a higher Aspergillus IgG level during the initial examination will help physicians to orient to further examination of CPA. Objectives: to determine the prevalence of aspergillosis in Koch's bacillus-positive and Koch's bacillus-negative PTB patients and antifungal resistance of Aspergillus species isolates in Central Asia countries.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 200 (estimated)
- First submitted
- 6 Sept 2021
- Start date
- 1 Jan 2020
- Primary completion date
- 31 Dec 2025
- Lead sponsor
- Research Institute of Epidemiology, Microbiology and Infectious Diseases, Uzbekistan
- Diseases
- Tuberculosis
- NCT number
- NCT05045391
What you commit to
- Study type: Observational
- Planned participants: 200
- From 1 Jan 2020 to the primary completion date, 31 Dec 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- hematopoietic stem cell or solid organ transplantation
Other illness
- severe immunosuppression caused by cancer chemotherapy
- HIV infected individuals
Other
- neutropenia
Who the study is looking for
- Pulmonary tuberculosis patients (smear-positive)
- Pulmonary tuberculosis patients (smear - negative)
Age in the registry: 19 years to 90 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Research institute of epidemiology, microbiology and infectious diseases Coordinator of this site? Confirm its status | Tashkent | Uzbekistan | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.